Emyria Ltd News

Emyria Ltd Showcases at 'Hidden Gems' Webinar

TipRanksSep 7 14:09 ET

Emyria Jumps 10% on 'Interim' Success Treating PTSD Patients With MDMA

The Market HeraldSep 1 20:53 ET

Emyria Ltd: Appendix 4E & Annual Report for the Year Ended 30 June 2024

Aug 30 00:35 ET · Announcements

Emyria Limited Shareholders Approve Key Resolutions

TipRanksAug 21 03:02 ET

Emyria Ltd Reports Strong Growth in Mental Health Sector

TipRanksJul 29 21:08 ET

David Pevcic Becomes Major Stakeholder in Emyria Ltd

TipRanksJul 15 05:30 ET

Sufian Ahmad Ends Substantial Holding in Emyria Ltd

TipRanksJul 15 05:29 ET

Emyria Receives Grant to Develop MDMA Analog Drug Program; Shares Up 17%

MT NewswiresJun 30 23:00 ET

Emyria to Facilitate PTSD Treatment Trial

MT NewswiresJun 19 20:06 ET

Emyria CFO Steps Down

MT NewswiresJun 10 19:50 ET

Emyria Ltd Advances Mental Health Treatments

TipRanksApr 25 20:09 ET

Emyria to Raise AU$2.3 Million via Placement

MT NewswiresApr 22 21:19 ET

Emyria Launches Empax Center

MT NewswiresApr 9 20:52 ET

Emyria's Second Psychiatrist Receives Authorized Prescriber Status From TGA

MT NewswiresApr 4 22:43 ET

Emyria Signs Study Agreement for MDMA-Assisted Therapy; Shares Up 7%

MT NewswiresApr 2 19:47 ET

Emyria Secures AU$2.5 Million R&D Tax Rebate for Fiscal Year 2023

MT NewswiresJan 14 22:00 ET

Stocks of the Hour: Gladiator Resources, Kali Metals, Emyria

sharecafeJan 9 19:43 ET

Australian Medical Regulator Grants 'Authorized Prescriber' Status to Emyria's Specialist Psychiatrist; Shares Soar 19%

MT NewswiresJan 9 19:32 ET

It's Unlikely That Shareholders Will Increase Emyria Limited's (ASX:EMD) Compensation By Much This Year

Yahoo FinanceNov 9, 2023 15:32 ET

Emyria Secures Canadian Regulatory Clearance to Import MDMA to Australia; Shares Fall 3%

MT NewswiresOct 18, 2023 22:55 ET